-
Published26/02/2025
-
Today25/03/2025
-
Deadline15/04/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Health products for drug supply for the years 2025-2028 (34 months), as of 01 07 2025 for the GCS ASO Text automatically translated in your browsing language Automatically translated
Framework agreement of the Occitanie GCS ASO Health Purchasing Cooperation Group for supplies of pharmaceutical products: medicines for ATC families: A, C, J, L, N, V for 22 lots - serotonin antagonist (5HT3) adult chemo inj, serotonin antagonist (5HT3) post-op inj, oral aprepitant, phloroglucinol 160 mg oral, bosentan oral, diltiazem 60 mg oral, verapamil 240 mg cp secable lp oral, iec ramipril oral, ceftriaxone 1000 mg im inj, vancomycin inj, eribuline inj, pomalidomide oral, midazolam inj, carbamazepine lp oral, alprazolam 1 mg oral, clozapine oral, quetiapine lp oral, risperidone comprime oral, buprenorphine oral, naltrexone 50 mg oral, sodium oxybate suspuv buv, sugammadex inj Text automatically translated in your browsing language Automatically translated
https://www.achatpublic.com/sdm/ent2/gen/ficheCsl.action?PCSLID=CSL_2025_9RtL16a9UG
https://www.achatpublic.com/sdm/ent2/gen/ficheCsl.action?PCSLID=CSL_2025_9RtL16a9UG
33600000 - Pharmaceutical products
33660000 - Medicinal products for the nervous system and sensory organs CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.